Sascan Meditech Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.92 M
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 340.13%
- Profit Growth 106.55%
- Ebitda 79.19%
- Net Worth 166.57%
- Total Assets 179.45%
About Sascan Meditech
Sascan Meditech Private Limited (SMPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 July 2015 (Nine years and six months 21 days old ). Its registered office is in Thiruvananthapuram, Kerala, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.92 M, as per Ministry of Corporate Affairs (MCA) records.
Usha Subhash and Subhash Narayanan serve as directors at the Company.
Company Details
-
Location
Thiruvananthapuram, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U33110KL2015PTC068448
-
Company No.
081578
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Jul 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
What products or services does Sascan Meditech Private Limited offer?
Sascan Meditech Private Limited offers a wide range of products and services, including Medical Consultants & Clinics, Medical Consultancy Services, Medical Surgery & Treatment Centres, Medical Treatment Services.
Who are the key members and board of directors at Sascan Meditech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subhash Narayanan
|
Director | 14-Jul-2015 | Current |
|
Usha Subhash
|
Director | 16-Jul-2016 | Current |
Financial Performance of Sascan Meditech.
Sascan Meditech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 340.13% increase. The company also saw a substantial improvement in profitability, with a 106.55% increase in profit. The company's net worth Soared by an impressive increase of 166.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sascan Meditech?
In 2022, Sascan Meditech had a public holding of 19.13%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sascan Meditech?
Unlock and access historical data on people associated with Sascan Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sascan Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sascan Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
